Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors

M. Li, P. A. Hantzopoulos, D. Banerjee, S. C. Zhao, B. I. Schweitzer, Eli Gilboa, J. R. Bertino

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

To determine the effect of different promoters on the expression of an altered dihydrofolate reductase (DHFR) gene conferring methotrexate (MTX) resistance in different cell types, double-copy retroviral vectors were constructed carrying a murine mutant DHFR under the control of five different promoters, i.e., human adenosine deaminase (ADA), simian virus 40 (SV40), thymidine kinase (TK), human β-actin, and cytomegalovirus (CMV). Their expression was compared in NIH-3T3 cells, three human leukemia cell lines, and mouse bone marrow. The variant DHFR is readily expressed from these various promoters in retroviral vectors at a selectable level. In 3T3 cells, the DHFR constructs containing the SV40 promoter conferred the highest levels of resistance to MTX. In K562 and Raji cells, the construct with the TK promoter produced the highest level of resistance. However granulocyte-macrophage colony-forming unit (CFU-GM) colonies from mouse marrow were more resistant to MTX when infected with vectors containing the SV40 promoter and ADA promoter as compared to the other promoter constructs. These studies show that, mouse fibroblast cell lines such as NIH-3T3 do not predict the effectiveness of retroviral-mediated gene transfer for marrow progenitor cells, and that the activity of retroviral vector-encoded promoters vary in an unpredictable manner from cell type to cell type. Possible implications for basic gene transfer studies and clinical applications are discussed.

Original languageEnglish
Pages (from-to)381-390
Number of pages10
JournalHuman Gene Therapy
Volume3
Issue number4
StatePublished - Dec 1 1992
Externally publishedYes

Fingerprint

Tetrahydrofolate Dehydrogenase
Simian virus 40
Methotrexate
Granulocyte-Macrophage Progenitor Cells
Thymidine Kinase
Bone Marrow
Genes
Cell Line
3T3 Cells
NIH 3T3 Cells
Adenosine Deaminase
K562 Cells
Cytomegalovirus
Actins
Leukemia
Stem Cells
Fibroblasts

ASJC Scopus subject areas

  • Genetics

Cite this

Li, M., Hantzopoulos, P. A., Banerjee, D., Zhao, S. C., Schweitzer, B. I., Gilboa, E., & Bertino, J. R. (1992). Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. Human Gene Therapy, 3(4), 381-390.

Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. / Li, M.; Hantzopoulos, P. A.; Banerjee, D.; Zhao, S. C.; Schweitzer, B. I.; Gilboa, Eli; Bertino, J. R.

In: Human Gene Therapy, Vol. 3, No. 4, 01.12.1992, p. 381-390.

Research output: Contribution to journalArticle

Li, M, Hantzopoulos, PA, Banerjee, D, Zhao, SC, Schweitzer, BI, Gilboa, E & Bertino, JR 1992, 'Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors', Human Gene Therapy, vol. 3, no. 4, pp. 381-390.
Li, M. ; Hantzopoulos, P. A. ; Banerjee, D. ; Zhao, S. C. ; Schweitzer, B. I. ; Gilboa, Eli ; Bertino, J. R. / Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. In: Human Gene Therapy. 1992 ; Vol. 3, No. 4. pp. 381-390.
@article{9a906d492c6444e3b9f0902816bb3e6d,
title = "Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors",
abstract = "To determine the effect of different promoters on the expression of an altered dihydrofolate reductase (DHFR) gene conferring methotrexate (MTX) resistance in different cell types, double-copy retroviral vectors were constructed carrying a murine mutant DHFR under the control of five different promoters, i.e., human adenosine deaminase (ADA), simian virus 40 (SV40), thymidine kinase (TK), human β-actin, and cytomegalovirus (CMV). Their expression was compared in NIH-3T3 cells, three human leukemia cell lines, and mouse bone marrow. The variant DHFR is readily expressed from these various promoters in retroviral vectors at a selectable level. In 3T3 cells, the DHFR constructs containing the SV40 promoter conferred the highest levels of resistance to MTX. In K562 and Raji cells, the construct with the TK promoter produced the highest level of resistance. However granulocyte-macrophage colony-forming unit (CFU-GM) colonies from mouse marrow were more resistant to MTX when infected with vectors containing the SV40 promoter and ADA promoter as compared to the other promoter constructs. These studies show that, mouse fibroblast cell lines such as NIH-3T3 do not predict the effectiveness of retroviral-mediated gene transfer for marrow progenitor cells, and that the activity of retroviral vector-encoded promoters vary in an unpredictable manner from cell type to cell type. Possible implications for basic gene transfer studies and clinical applications are discussed.",
author = "M. Li and Hantzopoulos, {P. A.} and D. Banerjee and Zhao, {S. C.} and Schweitzer, {B. I.} and Eli Gilboa and Bertino, {J. R.}",
year = "1992",
month = "12",
day = "1",
language = "English",
volume = "3",
pages = "381--390",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors

AU - Li, M.

AU - Hantzopoulos, P. A.

AU - Banerjee, D.

AU - Zhao, S. C.

AU - Schweitzer, B. I.

AU - Gilboa, Eli

AU - Bertino, J. R.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - To determine the effect of different promoters on the expression of an altered dihydrofolate reductase (DHFR) gene conferring methotrexate (MTX) resistance in different cell types, double-copy retroviral vectors were constructed carrying a murine mutant DHFR under the control of five different promoters, i.e., human adenosine deaminase (ADA), simian virus 40 (SV40), thymidine kinase (TK), human β-actin, and cytomegalovirus (CMV). Their expression was compared in NIH-3T3 cells, three human leukemia cell lines, and mouse bone marrow. The variant DHFR is readily expressed from these various promoters in retroviral vectors at a selectable level. In 3T3 cells, the DHFR constructs containing the SV40 promoter conferred the highest levels of resistance to MTX. In K562 and Raji cells, the construct with the TK promoter produced the highest level of resistance. However granulocyte-macrophage colony-forming unit (CFU-GM) colonies from mouse marrow were more resistant to MTX when infected with vectors containing the SV40 promoter and ADA promoter as compared to the other promoter constructs. These studies show that, mouse fibroblast cell lines such as NIH-3T3 do not predict the effectiveness of retroviral-mediated gene transfer for marrow progenitor cells, and that the activity of retroviral vector-encoded promoters vary in an unpredictable manner from cell type to cell type. Possible implications for basic gene transfer studies and clinical applications are discussed.

AB - To determine the effect of different promoters on the expression of an altered dihydrofolate reductase (DHFR) gene conferring methotrexate (MTX) resistance in different cell types, double-copy retroviral vectors were constructed carrying a murine mutant DHFR under the control of five different promoters, i.e., human adenosine deaminase (ADA), simian virus 40 (SV40), thymidine kinase (TK), human β-actin, and cytomegalovirus (CMV). Their expression was compared in NIH-3T3 cells, three human leukemia cell lines, and mouse bone marrow. The variant DHFR is readily expressed from these various promoters in retroviral vectors at a selectable level. In 3T3 cells, the DHFR constructs containing the SV40 promoter conferred the highest levels of resistance to MTX. In K562 and Raji cells, the construct with the TK promoter produced the highest level of resistance. However granulocyte-macrophage colony-forming unit (CFU-GM) colonies from mouse marrow were more resistant to MTX when infected with vectors containing the SV40 promoter and ADA promoter as compared to the other promoter constructs. These studies show that, mouse fibroblast cell lines such as NIH-3T3 do not predict the effectiveness of retroviral-mediated gene transfer for marrow progenitor cells, and that the activity of retroviral vector-encoded promoters vary in an unpredictable manner from cell type to cell type. Possible implications for basic gene transfer studies and clinical applications are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026903297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026903297&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 381

EP - 390

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 4

ER -